Xiaoyan Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaoyan Xie has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Yijun Gao
Department of Stomatology, the Second Xiangya Hospital, Central South University, Changsha 410011, China
13 shared publicationsLiming He
12 shared publicationsWenhui Ge
Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, China
12 shared publicationsYiyu Zeng
Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, China; Department of Otorhinolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
11 shared publicationsYi Yu
Department of Stomatology, The Second Xiangya Hospital, Central South University, Changsha, China
10 shared publicationsShuangjiang Li
5 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (5) , 109539
Digital Analysis of Upper Airway Morphology in Obstructive Sleep Apnea Syndrome Using Cone Beam Computed Tomography
- 8 July 2026
- Published by Elsevier in International Dental Journal
- Vol. 76 (5) , 109539
Open AccessDigital Analysis of Upper Airway Morphology in Obstructive Sleep Apnea Syndrome Using Cone Beam Computed Tomography
- Open Access
- 27 June 2026
- Published by Elsevier in SSRN Electronic Journal
Multifunctional Exosome-Infused Antimicrobial Mouthwash for Oral Ulcer Treatment
Oral ulcers are common and recurrent, yet existing mouthwashes face limitations due to single-target effects, compositional complexity, or immunogenicity risks. Here, we develop a multifunctional composite mouthwash (E-C-MW) by integrating mesenchymal stem cell-derived exosomes (Exo) with cetylpyridinium chloride (CPC). Unlike growth factors or herbal mixtures, Exo offer intrinsic multi-target regulatory capacity within a naturally derived, providing a more biomimetic and mechanistically distinct approach to tissue repair. The rinse formulation of E-C-MW offers distinct advantages for oral ulcer management. E-C-MW is easy to use with high patient compliance and comfort, particularly given the significant pain associated with ulcer flare-ups. Moreover, its liquid nature allows superior coverage of posterior or anatomically hidden ulcers that are difficult to reach by other topical dosage forms. Within this convenient and comfortable rinse, E-C-MW achieves broad-spectrum antimicrobial action while actively promoting healing. In a rat oral ulcer model, E-C-MW significantly accelerates healing, outperforming common commercial mouthwashes and single-component treatments. By establishing Exo as a viable bioactive platform in daily oral care, this study not only provides a promising strategy for recurrent oral ulcers but also opens new directions for developing multifunctional therapeutic mouthwashes for oral mucosal diseases.
- 27 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMultifunctional Exosome-Infused Antimicrobial Mouthwash for Oral Ulcer Treatment
Oral ulcers are common and recurrent, yet existing mouthwashes face limitations due to single-target effects, compositional complexity, or immunogenicity risks. Here, we develop a multifunctional composite mouthwash (E-C-MW) by integrating mesenchymal stem cell-derived exosomes (Exo) with cetylpyridinium chloride (CPC). Unlike growth factors or herbal mixtures, Exo offer intrinsic multi-target regulatory capacity within a naturally derived, providing a more biomimetic and mechanistically distinct approach to tissue repair. The rinse formulation of E-C-MW offers distinct advantages for oral ulcer management. E-C-MW is easy to use with high patient compliance and comfort, particularly given the significant pain associated with ulcer flare-ups. Moreover, its liquid nature allows superior coverage of posterior or anatomically hidden ulcers that are difficult to reach by other topical dosage forms. Within this convenient and comfortable rinse, E-C-MW achieves broad-spectrum antimicrobial action while actively promoting healing. In a rat oral ulcer model, E-C-MW significantly accelerates healing, outperforming common commercial mouthwashes and single-component treatments. By establishing Exo as a viable bioactive platform in daily oral care, this study not only provides a promising strategy for recurrent oral ulcers but also opens new directions for developing multifunctional therapeutic mouthwashes for oral mucosal diseases.
- Open Access
- 13 February 2026
- Published by Elsevier in SSRN Electronic Journal
Multifunctional Growth Factor Mouthwash Promotes Ulcer Healing
Oral aphthous ulcers represent a widespread inflammatory condition of the mucosal lining. These painful lesions cause significant functional impairment and clinical morbidity. Conventional therapeutic strategies however offer limited success in achieving comprehensive tissue regeneration. Because physiological wound healing requires the orchestrated interplay of multiple signaling molecules, monotherapies using single growth factors often fail to achieve coordinated tissue repair. To address this therapeutic gap, a multifunctional mouthwash was engineered by integrating five essential growth factors including PDGF, TGF beta, IGF, VEGF, and bFGF with the antimicrobial agent cetylpyridinium chloride. This design recapitulates the natural synergy of endogenous growth factors to synchronize pro-regenerative signaling with robust antimicrobial activity. In vitro optimization confirmed that this synergistic combination enhances epithelial and endothelial proliferation, accelerates cellular migration, and facilitates vascular network formation while polarizing macrophages toward a reparative phenotype. The formulation maintains high bactericidal efficacy without compromising the bioactivity of the therapeutic proteins. In a rat oral ulcer model, topical administration of the composite mouthwash markedly accelerated mucosal closure, augmented collagen deposition, and stimulated angiogenesis while suppressing pro-inflammatory cytokine expression. These findings demonstrate that the coordinated delivery of multiple growth factors within a stabilized antimicrobial microenvironment effectively promotes oral mucosal repair and offers a promising translational strategy for clinical ulcer management.
- 13 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMultifunctional Growth Factor Mouthwash Promotes Ulcer Healing
Oral aphthous ulcers represent a widespread inflammatory condition of the mucosal lining. These painful lesions cause significant functional impairment and clinical morbidity. Conventional therapeutic strategies however offer limited success in achieving comprehensive tissue regeneration. Because physiological wound healing requires the orchestrated interplay of multiple signaling molecules, monotherapies using single growth factors often fail to achieve coordinated tissue repair. To address this therapeutic gap, a multifunctional mouthwash was engineered by integrating five essential growth factors including PDGF, TGF beta, IGF, VEGF, and bFGF with the antimicrobial agent cetylpyridinium chloride. This design recapitulates the natural synergy of endogenous growth factors to synchronize pro-regenerative signaling with robust antimicrobial activity. In vitro optimization confirmed that this synergistic combination enhances epithelial and endothelial proliferation, accelerates cellular migration, and facilitates vascular network formation while polarizing macrophages toward a reparative phenotype. The formulation maintains high bactericidal efficacy without compromising the bioactivity of the therapeutic proteins. In a rat oral ulcer model, topical administration of the composite mouthwash markedly accelerated mucosal closure, augmented collagen deposition, and stimulated angiogenesis while suppressing pro-inflammatory cytokine expression. These findings demonstrate that the coordinated delivery of multiple growth factors within a stabilized antimicrobial microenvironment effectively promotes oral mucosal repair and offers a promising translational strategy for clinical ulcer management.
- Open Access
- 12 February 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102911
Designing adhesive hydrogels for oral diseases treatment
- 12 February 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102911
Open AccessDesigning adhesive hydrogels for oral diseases treatment
- Top Cited PapersOpen Access
- 9 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Core–shell microneedles with MMP/pH-triggered release for periodontitis bone repair
Periodontitis is a localized inflammatory condition triggered by periodontal pathogens and marked by uneven loss of alveolar bone. The clash between the pe
- 9 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Top Cited PapersOpen AccessCore–shell microneedles with MMP/pH-triggered release for periodontitis bone repair
Periodontitis is a localized inflammatory condition triggered by periodontal pathogens and marked by uneven loss of alveolar bone. The clash between the pe
- Open Access
- 5 November 2025
- Published by Elsevier in Materials Today Advances
- Vol. 28
Janus hydrogels: Pioneering dual-faced biomaterials for revolutionary tissue engineering
- 5 November 2025
- Published by Elsevier in Materials Today Advances
- Vol. 28
Open AccessJanus hydrogels: Pioneering dual-faced biomaterials for revolutionary tissue engineering
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Diagnosing malignant transformation potential in oral submucous fibrosis with leukoplakia: an approach utilizing deoxyribonucleic acid image cytometry
Oral submucous fibrosis (OSF) is a chronic oral condition with a potential for malignant transformation. This study aims to investigate the correlation between DNA aneuploidy and dysproliferative lesions in OSF using DNA image cytometry to provide insights into cancer risk assessment. The study included patients diagnosed with OSF, OSF combined with oral leukoplakia (OLK), OSF that progressed to oral squamous cell carcinoma (OSCC), and healthy controls. Exfoliated oral mucosal cells were collected and analyzed using DNA image cytometry. Statistical analyses were conducted using SPSS 22.0 to compare the results across different groups. The study revealed that DNA image cytometry demonstrated high sensitivity and specificity for diagnosing OSCC and epithelial dysplasia. Furthermore, the frequency of abnormal DNA content in oral exfoliated cells from patients with OSF + OLK significantly increased with the grade of abnormal histopathological epithelial proliferation. Significant differences in DNA content were observed between the OSF, OSF + OLK, and OSCC groups. Additionally, patients with OSF showed no significant difference in DNA content between the buccal and tongue mucosae, but those with OSF + OLK demonstrated differences in DNA content between the OSF and OLK lesion areas. DNA image cytometry is a valuable tool for assessing cancer risk in OSF patients, particularly those with coexisting OLK. The findings suggest that OSF + OLK patients have a higher risk of cancer than those with OSF alone, providing crucial scientific evidence for predicting cancer risk and guiding early intervention strategies.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Open AccessDiagnosing malignant transformation potential in oral submucous fibrosis with leukoplakia: an approach utilizing deoxyribonucleic acid image cytometry
Oral submucous fibrosis (OSF) is a chronic oral condition with a potential for malignant transformation. This study aims to investigate the correlation between DNA aneuploidy and dysproliferative lesions in OSF using DNA image cytometry to provide insights into cancer risk assessment. The study included patients diagnosed with OSF, OSF combined with oral leukoplakia (OLK), OSF that progressed to oral squamous cell carcinoma (OSCC), and healthy controls. Exfoliated oral mucosal cells were collected and analyzed using DNA image cytometry. Statistical analyses were conducted using SPSS 22.0 to compare the results across different groups. The study revealed that DNA image cytometry demonstrated high sensitivity and specificity for diagnosing OSCC and epithelial dysplasia. Furthermore, the frequency of abnormal DNA content in oral exfoliated cells from patients with OSF + OLK significantly increased with the grade of abnormal histopathological epithelial proliferation. Significant differences in DNA content were observed between the OSF, OSF + OLK, and OSCC groups. Additionally, patients with OSF showed no significant difference in DNA content between the buccal and tongue mucosae, but those with OSF + OLK demonstrated differences in DNA content between the OSF and OLK lesion areas. DNA image cytometry is a valuable tool for assessing cancer risk in OSF patients, particularly those with coexisting OLK. The findings suggest that OSF + OLK patients have a higher risk of cancer than those with OSF alone, providing crucial scientific evidence for predicting cancer risk and guiding early intervention strategies.
- 22 April 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 253, 114704
Smart self-assembled peptide-based hydrogels: Mechanism, design and biomedical applications
- 22 April 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 253, 114704
Smart self-assembled peptide-based hydrogels: Mechanism, design and biomedical applications
- Open Access
- 17 September 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-12
Comprehensive analysis of clinicopathological characteristics in oral squamous cell carcinoma arising from oral submucous fibrosis: a retrospective study
Background Oral squamous cell carcinoma arising from oral submucous fibrosis is recognized as a clinicopathologically distinct disease. This study aims to summarize and compare the population and clinicopathologic characteristics of OSCC-OSF with other OSCC in Hunan Province, China. The objective is to formulate treatment strategies more in line with regional characteristics. Methods A retrospective review of OSCC cases recruited from the Second Xiangya Hospital from 2010 to 2020 was conducted. A total of 1,413 OSCC patients were selected, including 481 patients with OSCC-OSF and 932 were other OSCC. Population characteristics, risk factors and clinicopathological manifestations were explored in OSCC-OSF and other OSCC, as well as thinprep cytologic test and DNA quantification. Results We found that OSCC-OSF patients were younger than those with other OSCC. Both types of disease were predominantly observed in males compared to females. Tumor biopsy analysis indicated that tumor cells within OSCC-OSF patients were more likely to be well differentiated and showed a higher frequency of lymph node metastases. Clinicopathological factors, such as the chewing betel nuts habit and smoking, were more prevalent in OSCC-OSF patients in contrast to other OSCC. DNA quantification revealed that the number of DNA aneuploid cells was higher in OSCC-OSF compared to other OSCCs. Conclusion In this study, OSCC-OSF is considered a clinicopathologically distinct disease. Compared with other OSCC, OSCC-OSF patients have a higher incidence of nodal metastases, an early clinical TNM stage, and a lower three-year survival rate. Therefore, early diagnosis and treatment are crucial to improving the prognosis of OSCC-OSF.
- 17 September 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-12
Open AccessComprehensive analysis of clinicopathological characteristics in oral squamous cell carcinoma arising from oral submucous fibrosis: a retrospective study
Background Oral squamous cell carcinoma arising from oral submucous fibrosis is recognized as a clinicopathologically distinct disease. This study aims to summarize and compare the population and clinicopathologic characteristics of OSCC-OSF with other OSCC in Hunan Province, China. The objective is to formulate treatment strategies more in line with regional characteristics. Methods A retrospective review of OSCC cases recruited from the Second Xiangya Hospital from 2010 to 2020 was conducted. A total of 1,413 OSCC patients were selected, including 481 patients with OSCC-OSF and 932 were other OSCC. Population characteristics, risk factors and clinicopathological manifestations were explored in OSCC-OSF and other OSCC, as well as thinprep cytologic test and DNA quantification. Results We found that OSCC-OSF patients were younger than those with other OSCC. Both types of disease were predominantly observed in males compared to females. Tumor biopsy analysis indicated that tumor cells within OSCC-OSF patients were more likely to be well differentiated and showed a higher frequency of lymph node metastases. Clinicopathological factors, such as the chewing betel nuts habit and smoking, were more prevalent in OSCC-OSF patients in contrast to other OSCC. DNA quantification revealed that the number of DNA aneuploid cells was higher in OSCC-OSF compared to other OSCCs. Conclusion In this study, OSCC-OSF is considered a clinicopathologically distinct disease. Compared with other OSCC, OSCC-OSF patients have a higher incidence of nodal metastases, an early clinical TNM stage, and a lower three-year survival rate. Therefore, early diagnosis and treatment are crucial to improving the prognosis of OSCC-OSF.
- Open Access
- 3 September 2024
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 25 (1) , 1-13
Comprehensive analysis of an mRNA co-expression network and a ceRNA network reveals potential prognostic biomarkers in oral squamous cell carcinoma
Background: Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive oral cancer with a poor prognosis. Its polygenic risk is likely influenced by complex transcriptional disorders involving networks of co-expressed and functionally related genes, though such investigations are limited in OSCC. Methods: We analyzed the GSE37991 dataset, comprising 40 OSCC and 40 normal oral tissue samples from the Gene Expression Omnibus. Tumor-specific modules were identified using weighted correlation network analysis (WGCNA), leading to the selection of hub mRNAs and lncRNAs. These lncRNAs were used to construct lncRNA–mRNA and competing endogenous RNA networks. We further examined the expression profiles and survival data of these genes from the Cancer Genome Atlas. Prognostic markers were identified and validated through 5-year survival analysis and Cox proportional hazards modeling. RT-qPCR was used to validate the expression levels in clinical OSCC tissues. Results: We identified 1847 differentially expressed genes in OSCC tissues. WGCNA revealed four OSCC-specific modules, screening 120 hub mRNAs and five hub lncRNAs. Two prognostic markers (AQP5, IL-26) from hub mRNAs and three (FRMD5, INHBB, GUCY1A3) from the lncRNA–mRNA network were associated with survival. Validation showed lower expression of AQP5 and GUCY1A3, and higher expression of FRMD5 and INHBB in OSCC compared to normal tissues. Conclusion: This study enhances our understanding of transcriptional dysregulation in OSCC and may highlights AQP5, IL-26, FRMD5, INHBB, and GUCY1A3 as promising prognostic biomarkers.
- 3 September 2024
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 25 (1) , 1-13
Open AccessComprehensive analysis of an mRNA co-expression network and a ceRNA network reveals potential prognostic biomarkers in oral squamous cell carcinoma
Background: Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive oral cancer with a poor prognosis. Its polygenic risk is likely influenced by complex transcriptional disorders involving networks of co-expressed and functionally related genes, though such investigations are limited in OSCC. Methods: We analyzed the GSE37991 dataset, comprising 40 OSCC and 40 normal oral tissue samples from the Gene Expression Omnibus. Tumor-specific modules were identified using weighted correlation network analysis (WGCNA), leading to the selection of hub mRNAs and lncRNAs. These lncRNAs were used to construct lncRNA–mRNA and competing endogenous RNA networks. We further examined the expression profiles and survival data of these genes from the Cancer Genome Atlas. Prognostic markers were identified and validated through 5-year survival analysis and Cox proportional hazards modeling. RT-qPCR was used to validate the expression levels in clinical OSCC tissues. Results: We identified 1847 differentially expressed genes in OSCC tissues. WGCNA revealed four OSCC-specific modules, screening 120 hub mRNAs and five hub lncRNAs. Two prognostic markers (AQP5, IL-26) from hub mRNAs and three (FRMD5, INHBB, GUCY1A3) from the lncRNA–mRNA network were associated with survival. Validation showed lower expression of AQP5 and GUCY1A3, and higher expression of FRMD5 and INHBB in OSCC compared to normal tissues. Conclusion: This study enhances our understanding of transcriptional dysregulation in OSCC and may highlights AQP5, IL-26, FRMD5, INHBB, and GUCY1A3 as promising prognostic biomarkers.